眼底照片视网膜微血管成像特征的量化:眼病与全身疾病的标准化框架
本文综述了视网膜微血管定量分析工具在眼病与全身疾病中的应用,指出工具间因图像处理步骤差异导致可比性差,影响可重复性与跨研究整合。作者提出标准化方法学框架以 harmonize 视网膜微血管量化,并列出关键开放问题。
要点
- 视网膜微血管定量工具因血管分割、动静脉分类等步骤差异导致结果不可比。
- 提出标准化框架以 harmonize 视网膜微血管量化,促进生物标志物开发。
- 关键开放问题包括微血管特征变化时机、可逆性及中央与周边差异。
核心结论
- 现有视网膜微血管分析工具因图像处理步骤差异导致可比性差,需标准化框架以推进稳健可扩展的生物标志物开发。
研究设计与样本
- 本文为综述,全面比较了现有用于静态血管分析的分析工具,并 delineate 方法学差异对血管测量量化的影响。
主要发现
- 工具差异源于图像处理步骤变化,包括血管分割、动静脉分类、视盘检测、感兴趣区定义、图像质量评估和指标计算算法。
- 工具间可比性差限制了可重复性和跨研究整合。
关键数值与推荐
- 提出了一个方法学框架以标准化和 harmonize 视网膜微血管量化。
临床怎么用
- 该框架可指导未来研究解决文献中的关键空白,并开发用于临床的成像生物标志物。
局限性
- 本文为综述,未报告原始研究数据;工具间差异的具体量化比较未在摘要中提供。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Microvascular dysfunction is increasingly recognized as an important contributor to ocular and systemic diseases, including diabetic retinopathy, cardiovascular disease, and Alzheimer's disease and related dementias. Elucidating how early microvascular injury contributes to disease pathobiology, and development of sensitive, quantifiable features of microvascular dysfunction, represents a critical frontier for improving risk stratification, enabling earlier diagnosis and guiding targeted interventions. In this context, retinal imaging has emerged as a powerful modality, enabling non-invasive, high-resolution visualization of the microvasculature with color and (ultra)widefield fundus imaging. Rapid technological advances have led to an array of, open-source tools for quantitative extraction of retinal microvascular features. However, progress in this field is hampered by poor comparability between tools, limiting reproducibility and cross-study integration. Differences between tools originate from variations in image processing steps, including vessel segmentation, arteriole-venule classification, optic disc detection, region-of-interest definition, image quality assessment, and the algorithms for metric calculation. In this review we comprehensively compare existing analytical analysis tools for static vessel analyses and delineate how these methodological differences influence the vascular measure quantification. To advance robust, scalable biomarker development, we propose a methodological framework to standardize and harmonize retinal microvascular quantification. This framework can guide future studies in addressing key gaps in literature and in developing imaging biomarkers for clinical use. Critical open questions include whether and when retinal imaging features change during ocular and systemic disease, whether microvascular dysfunction is reversible, how microvascular dysfunction contributes to neurodegeneration, and how central and peripheral retinal microvascular dysfunction differ.
引用
- van der Heide FC, Zamoum Y, Ounissi M, et al. Quantification of retinal microvascular imaging features from fundus photos in ocular and systemic disease: a framework for standardization. Prog Retin Eye Res. 2026. PMID: 41871655. doi:10.1016/j.preteyeres.2026.101461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。